All Stories

  1. Advantages of animal leather over alternatives and its medical applications
  2. Anti-NMDA Receptor Encephalitis, Human Papillomavirus, and microRNA
  3. Beneficial medicinal effects and material applications of rose
  4. The Potential of Collagen Treatment for Comorbid Diseases
  5. Tolerance limits for mixture‐of‐normal distributions with application to COVID‐19 data
  6. Biomaterials in Medical Applications
  7. The Human Pre-miRNA Distance Distribution for Exploring Disease Association
  8. microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration
  9. The distance distribution of human microRNAs in MirGeneDB database
  10. Phylogenetic Tree Selection by Testing Substitution Number in Clade
  11. Exploring the Causal Effect of Constipation on Parkinson’s Disease Through Mediation Analysis of Microbial Data
  12. A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson’s Disease
  13. COVID−19, Anti-NMDA Receptor Encephalitis and MicroRNA
  14. microRNA Biomarkers in Clinical Study
  15. Multiple imputation confidence intervals for the mean of the discrete distributions for incomplete data
  16. A Review of the Effects of Collagen Treatment in Clinical Studies
  17. The Association between Migraine and Depression based on miRNA Biomarkers and Cohort Studies
  18. MicroRNAs, Multiple Sclerosis, and Depression
  19. Editorial: miRNAs and Neurological Diseases
  20. MicroRNAs, Parkinson’s Disease, and Diabetes Mellitus
  21. Confidence intervals for the proportion of conformance
  22. Exploring the Association of Autism Spectrum Disorders and Constipation through Analysis of the Gut Microbiome
  23. Phylogenetic analysis of microRNA biomarkers for amyotrophic lateral sclerosis
  24. The Generalized Bayes Method for High-Dimensional Data Recognition with Applications to Audio Signal Recognition
  25. MicroRNA, Diabetes Mellitus and Colorectal Cancer
  26. The Association between Depression and Gastroesophageal Reflux based on Phylogenetic Analysis of miRNA Biomarkers
  27. <p>Exploring Diversity of COVID‑19 Based on Substitution Distance</p>
  28. Monitoring Change Points by a Sign Change Method
  29. MicroRNAs and Apoptosis in Colorectal Cancer
  30. Constructing exact tolerance intervals for the exponential distribution based on record values
  31. Anti-NMDA Receptor Encephalitis: Efficacy of Treatment for Male Patients and miRNA Biomarker
  32. Logistic Regression Method for Ligand Discovery
  33. Exact two‐sided tolerance interval controlling tail proportions for sample variances
  34. Anti-NMDA Receptor Encephalitis, Vaccination and Virus
  35. Vaccines and Neurological Disease
  36. Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers
  37. Tolerance interval for the mixture normal distribution
  38. Exploring MicroRNA Biomarkers for Parkinson’s Disease from mRNA Expression Profiles
  39. How can we identify Amyotrophic Lateral Sclerosis with blood test?
  40. A protocol for investigating the association of vaccination and anti-NMDA receptor encephalitis
  41. Constructing Tolerance Intervals for the Number of Defectives Using Both High- and Low-Resolution Data
  42. Why ALS is often associated with cancers?
  43. A control chart for the lognormal standard deviation
  44. Anti-NMDA Receptor Encephalitis and Vaccination
  45. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis
  46. On the monitoring of mixture simple linear profiles
  47. Efficacies of treatments for anti-NMDA receptor encephalitis
  48. Corrigendum to “Variance estimation for nucleotide substitution models” [Mol. Phylogenet. Evol. 90 (2015) 97–103]
  49. Multivariate control charts based on the James–Stein estimator
  50. Variance estimation for nucleotide substitution models
  51. Control Charts for the Lognormal Mean
  52. Predicting Cancer-Related MiRNAs Using Expression Profiles in Tumor Tissue
  53. Correction: Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  54. Investigating microRNA-Target Interaction-Supported Tissues in Human Cancer Tissues Based on miRNA and Target Gene Expression Profiling
  55. Shrinkage regression-based methods for microarray missing value imputation
  56. RRSM with a data-dependent threshold for miRNA target prediction
  57. Bayesian Ranking Responses in Multiple-Response Questions
  58. Protein-specific Scoring Method for Ligand Discovery
  59. Confidence intervals for a bounded mean in exponential families
  60. Phylogenetic tree selection by the adjustedk-means approach
  61. Human microRNA target identification by RRSM
  62. Yeast cell cycle transcription factors identification by variable selection criteria
  63. Confidence intervals for the substitution number in the nucleotide substitution models
  64. Constructing Biological Pathways by a Two-Step Counting Approach
  65. Approximate Tolerance Limits Under Log-Location-Scale Regression Models in the Presence of Censoring
  66. Closed Form Prediction Intervals Applied for Disease Counts
  67. The monotone boundary property and the full coverage property of confidence intervals for a binomial proportion
  68. Comparison of control charts for low defective rate
  69. Increasing MicroRNA target prediction confidence by the relative R2 method
  70. Tolerance Intervals With Improved Coverage Probabilities for Binomial and Poisson Variables
  71. Improved variance estimators for one- and two-parameter models of nucleotide substitution
  72. Confidence intervals for the mean of a normal distribution with restricted parameter space
  73. Coverage probability of prediction intervals for discrete random variables
  74. Exact average coverage probabilities and confidence coefficients of confidence intervals for discrete distributions
  75. Exact confidence coefficients of simultaneous confidence intervals for multinomial proportions
  76. Ranking responses in multiple-choice questions
  77. ϵ-Admissible Estimators for Normal and Poisson Means
  78. Estimation of the Probability of Passing the USP Dissolution Test
  79. Modified p-values for one-sided testing in restricted parameter spaces
  80. Modified p-Value of Two-Sided Test for Normal Distribution with Restricted Parameter Space
  81. Improved confidence estimators for confidence sets of location parameters
  82. Improved estimation of accuracy in simple hypothesis versus simple alternative testing
  83. Improved confidence estimators for the usual one-sided confidence intervals for the ratio of two normal variances
  84. Admissibility of Confidence Estimators in the Regression Model
  85. The problem of low counts in a signal plus noise model
  86. Brown's paradox in the estimated confidence approach
  87. Estimated confidence under ancillary statistic everywhere-valid constraint
  88. Admissibility of the constant-coverage probability estimator for estimating the coverage function of certain confidence interval